1 of 2
Trump Cuts Drug Prices
- U.S. President Donald Trump announced agreements with nine pharmaceutical companies to reduce drug prices for Medicaid and cash payers under most-favored-nation pricing strategy.
- The deals aim to align U.S. drug costs with prices in other wealthy nations and require drugmakers to contribute to a strategic reserve of active pharmaceutical ingredients for emergencies.
- The TrumpRx platform will launch in January to provide discounted medications, but experts caution benefits may be limited.
1 / 2
